Keymed Biosciences Co.ltd

This study tested an investigational injection called CM310 to see if it could safely reduce the symptoms of moderate-to-severe eczema in teenagers. 180 participants were randomly assigned to receive either the real drug or a placebo (a dummy injection) for 18 weeks. Researchers …

This first-in-human study tested a new drug called CM512 to see if it is safe for people. It involved both healthy volunteers and patients with moderate to severe eczema. The main goal was to check for side effects and see how the drug moves through the body at different doses.